Reversal of hepatorenal syndrome and kidney recovery: When renal has more to offer

Semin Dial. 2022 Jul;35(4):366-371. doi: 10.1111/sdi.13083. Epub 2022 Apr 22.

Abstract

Hepatorenal syndrome (HRS) is one of the most severe complications in advanced cirrhosis. Type-1 HRS is relatively uncommon, yet carries considerably higher mortality rate. Effective treatment for HRS, especially therapy towards survival benefits, is still limited. However, the role for dialysis in HRS has been questioned over the years. The initiation of dialysis remains controversial for those who aren't transplant candidates. Meanwhile, there's a growing attention towards the successful use of peritoneal dialysis (PD) in cirrhotic patients. Herein, we report a case of HRS-1 in a 76-year-old male patient with decompensated cirrhosis. Through a series of adjustments of hemodialysis regimens and pharmacological prescriptions, patient stabilized and the opportunity for transjugular intrahepatic portosystemic shunt (TIPS) insertion was gained. PD was initiated after TIPS placement. With a gradual decrease of dialysis dose, patient successfully weaned off PD and achieved both reversal of HRS and kidney recovery. Markedly improved nutritional status and quality of life were reported. The potential role of dialysis and TIPS in HRS may be worth revisiting. Further studies regarding the optimal timing of dialysis initiation, choices of dialysis modality, and efficacy of dialysis therapy in combination with TIPS in HRS patients are warranted.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Hepatorenal Syndrome* / etiology
  • Hepatorenal Syndrome* / therapy
  • Humans
  • Kidney
  • Liver Cirrhosis / complications
  • Liver Transplantation* / adverse effects
  • Male
  • Portasystemic Shunt, Transjugular Intrahepatic* / adverse effects
  • Quality of Life
  • Renal Dialysis / adverse effects